Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia

Abstract excerpt

D ESPITE ITS well-known sensitivity to anthracyclines,[1-5][1] acute promyelocytic leukemia (APL) was catalogued until the late 1980s as one of the most rapidly fatal human tumors, with the majority of patients dying early of intractable hemorrhage or disease relapse.[6][2] Two major research

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Antioxidant Activity and Oxidative Stress
• Share to Retinoids in leukemia and cellular processes